| 2018 |
Current Status of Early Phase Trials
|
|
Smart Design of Early Phase Trials
|
| 2019 |
Integrated platform for precision medicine
|
|
Utilization of NGS to improve patient care
|
| 2020 |
(ASCO Breakthrough Session) Bench to bedside research in oncology
|
|
Accelerating precision medicine in real-world and utilizing real-world evidence
|
| 2021 |
Integrating next-generation sequencing into clinical practices: Sharing the real-world experiences
|
|
Ladder of cancer treatment: Precision medicine and palliative care
|
| 2022 |
Application of precision medicine in rare cancers: Approaching genetic landscape into rare cancers
|
|
Hereditary cancers: Diagnosis, management, and clinical trials
|
| 2023 |
Targeting rare genomic aberrations in precision oncology
|
|
Role of immune system in tumorigenesis and targeting immune microenvironment
|
| 2024 |
Oncology innovations in cancer care - Translating new discoveries into treatment for patients with cancer
|
|
Optimal palliative care for cancer patients
|
| 2025 |
New horizon on gastroesophageal cancer treatment
|
|
The impact of NGS testing in oncology patients
|
